Dear Colleague
The final update of concessionary prices were granted today for November 2025:
DrugPack SizeConcessionary Price
Amiodarone 200mg tablets28£5.99
Aripiprazole 2.5mg tablets28£31.14
Carbocisteine 375mg capsules120£2.95
Estriol 0.01% vaginal cream with applicator1£47.05
Pyridostigmine bromide 60mg tablets200£15.79
Repaglinide 1mg tablets90£31.73
Sitagliptin 100mg/5ml oral solution sugar free150£21.85

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Colleague,

Registrants received an email from NICPLD earlier this week inviting invitations from Pharmacists in NI to apply to two fully funded places on the UK’s CPO sponsored Pharmacy Leaders Programme taking place in 2026.

This pharmacy leaders development programme is for experienced pharmacists who aspire to lead large and complex NHS departments, community pharmacies, services, teams or systems of care to benefit patients and local communities. It aims to develop knowledge, skills, attitudes and behaviours to help experienced pharmacy professionals become outstanding, compassionate and inclusive leaders, and improve the performance of the teams and the people who work with them to deliver improved outcomes for patients and the public.

This programme aims to create a cohort of senior pharmacy professionals ready for challenging senior leadership roles and to develop networks to sustain their professional leadership practice. A key objective is to make a positive contribution to improving the diversity of those in senior pharmacy professional leadership positions in the NHS.

It offers a comprehensive mix of residential workshops, optional online specialist study days, and small group support to build capability, confidence and networks across the wider system.

This programme is developed by CPPE in collaboration with senior leaders and in 2026, two places will be available for pharmacists working in Northern Ireland.

NICPLD will hold an information webinar on 18 December 2025 at 7pm to explain more about the programme and the application process for pharmacists in NI.

Further information on this unique opportunity is available here or can be obtained by contacting either NICPLD or CPNI offices directly.

Yours sincerely,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Colleague,

CPNI is aware of the ongoing pressure that can be put on community pharmacies to supply medicines in monitored dosage systems to new patients. These requests can come from Trusts, carers, family members, the patient themselves or others. With the mounting pressure on the Health Service it is likely that these requests will grow.

When faced with these requests contractors and pharmacy teams are asked to consider the following:

  1. The information and clarification previously provided by CPNI in CPNI CU#240126B: Community Pharmacy Adherence Support and specifically point 3 in the letter which remains valid and may be useful when dealing with such requests from Trust colleagues or domiciliary care providers.
  2. The clarification and information contained in SPPG letters issued in September 2025 and included in CPNI CU#250922B: Adherence Support remain in place.
  3. Contractors are reminded that funding associated with dispensing of medicines is unchanged from the SPPG letters referred to in (b) above and also in the SPPG Funding Update letter, dated 23rd July 2025.

Please do not hesitate to contact CPNI offices if you require any additional information.

Yours sincerely,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
SPPG issued correspondence on 28 November 2025 regarding the new Model Complaints Handling Procedure (MCHP) which will be fully implemented on 1st January 2026.

SUMMARY

ACTION

  • Contractors are asked to review the SPPG correspondence issued on 28 November 2025 and share with all relevant members of the pharmacy team.

For further information please contact your SPPG pharmacy advisor in the first instance or speak to a member of the CPNI team.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
**FOR THE ATTENTION OF LIVING WELL PHARMACIES ONLY**
Dear Contractor
Correspondence has been issued by SPPG on 01 December 2025 regarding the launch of the Living Well survey for the campaign ‘Stay well this winter’.

SUMMARY

  • The survey for the campaign ‘Stay well this winter’ is open and can be accessed here.
  • The survey must be completed by 6pm on Monday 12th January 2026. Please ensure to reach the final screen to confirm submission.
  • Note: You may wish to take a screen shot of the final screen for your own records.

ACTION

  • Contractors are asked to review the SPPG correspondence issued on 01 December 2025 and share with all relevant members of the pharmacy team.

For any further information please contact your SPPG pharmacy advisor or a member of the CPNI team.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Updated Legislation on Wet Wipes containing Plastic

The Department for Agriculture, Environment and Rural Affairs (DAERA) has made CPNI aware that The Environmental Protection (Wet Wipes Containing Plastic) Regulations (Northern Ireland) 2025 were made on 18 November 2025 with an 18-month transition period.

The legislation introduces a ban on the sale and supply of wet wipes including plastic in NI but includes some exceptions for sale from community pharmacies.  Further information is available here on the DAERA website.  An FAQ document which includes information on the exemption for community pharmacies is available here.

Queries can be addressed to Singleuseplastics@daera-ni.gov.uk.

Current Pharmacy Consultations 

Below is a summary of pharmacy-related consultations which community pharmacy contractors and their teams may wish to consider.

Post Registration Training and Development
The Royal Pharmaceutical Society (RPS) is currently updating the existing post-registration Foundation curriculum.  The revised curriculum will be re-named the RPS Enhanced curriculum and will launch in Summer 2026 to align with the first cohort of FTY trainees registering as IP pharmacists.  NICPLD is developing an Enhanced pharmacist programme, which will deliver the new RPS curriculum.  This is expected to be available from October 2026 and more information is available here.  In preparation for the changes, RPS is conducting a consultation on the first two domains of the new Enhanced curriculum and survey responses are welcomed from all sectors of the profession before the closing date on 1 December 2025.

Pharmacist Flexibilities when Dispensing Prescribed Medicines
The Department of Health and Social Care (DHSC) is currently consulting on changes to medicines legislation to increase pharmacist flexibilities when dispensing medicines.  The proposals include enabling pharmacists working in a community pharmacy to supply a different strength or formulation (which may mean a different quantity) of a prescribed medicine, in certain circumstances.  Further information is available here, and responses can be submitted via the online survey before the closing date on 11 December 2025.

GPhC Pharmacy Technician Education Standards
The GPhC as the regulator of pharmacists and pharmacy technicians in England, Scotland and Wales, is currently consulting on revised education and training standards for registered pharmacy technicians.  Responses are welcomed via the online survey before the closing date of 24 December 2025.  Note: While pharmacy technicians in NI are not yet registered health professionals, the Chief Pharmaceutical Officer and PSNI Chief Executive are jointly leading work towards technician registration.  The project newsletters are available here, and a recent update from the project Chairs is available here.

PSNI Consultation on Draft Guidance for Prescription Collection and Delivery
The Pharmaceutical Society of Northern Ireland (PSNI) has launched a consultation on draft guidance for prescription collection and delivery in Northern Ireland.  The draft guidance, equality impact assessment and consultation questions are available on the PSNI website here, and responses will be accepted up to the closing date on 2 February 2026.

Daffodil Standards – Further to CPNI CPNI CU#250923A
The Daffodil Standards are a joint initiative between the Royal Pharmaceutical Society and Marie Curie and are supported by the Department of Health, Pharmacy Forum NI and Community Pharmacy NI.  Designed to build on the high level of care already provided to palliative care patients and their families by community pharmacy teams, the Daffodil Standards provide a clear, practical framework to help plan and deliver end-of-life care during these challenging months.

Since launching at the end of March, 90 community pharmacies in Northern Ireland have signed up to the initiative and the feedback has been positive, with pharmacists commenting that they would encourage pharmacy teams to get involved, as by doing so they will get additional information and support to help build their confidence in providing palliative and end of life care.

Further information is available here.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive